ArticleScientific reports2020

Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model.

F Andreata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.